Role of cMET in the development and progression of colorectal cancer
about
Recent updates of precision therapy for gastric cancer: Towards optimal tailored managementThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careThe challenge of developmental therapeutics for adrenocortical carcinomaStroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitorsMet receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions.c-MET immunostaining in colorectal carcinoma is associated with local disease recurrencePeritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational studyA randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapyRole of met axis in head and neck cancer.Dependence receptors and colorectal cancer.Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical Trial.A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.The c-Met receptor: Implication for targeted therapies in colorectal cancer.C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome.Underlying Mechanisms for Distant Metastasis - Molecular Biology.Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma.
P2860
Q26746246-27D991E4-0EDB-413B-BA5A-7269E9A5CCA1Q28066460-D59CDEC2-C0D8-4B57-98FC-7702206C8865Q28072970-336056F4-FAF7-4DCE-BAD4-2D700B3644B7Q33888739-BDC517AB-EA40-4CBE-B8D0-DC0D2B4464B4Q35141465-977DFF89-2F3A-4E42-9BA7-96908F836E3EQ35804089-D1500ECD-2627-4940-9062-5565102C87F1Q35955331-090FED4D-4C92-47E9-950C-9D52F48DE582Q36879706-E4F3CFB8-1DE7-450A-B145-0D5A7684A30AQ37352435-B95BACCA-C572-42EF-B566-857B69D54A89Q38167258-C44B3D89-B110-4D93-869C-D9A0F8D2998FQ38243917-6DD6FF8F-C806-4163-A83B-990231A81210Q38259956-34298AA6-785C-4659-A318-9AEC04F49010Q38383859-CF6A0B20-F1EC-434E-9E7C-C5667B2A5007Q38956448-DE57780E-75B6-449F-B5A5-8616E6D31FCCQ39274990-C8F74EBF-19C4-4E79-ACD5-C8CE8FE11E3FQ39866108-964971F3-E215-423D-8E37-4E779155BBFDQ40102636-D43BCE23-95D8-4776-805B-62C8C54FF9C1Q49887930-7C0CB0BF-1C85-4D4E-A170-4F6106A2F7AF
P2860
Role of cMET in the development and progression of colorectal cancer
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Role of cMET in the development and progression of colorectal cancer
@en
type
label
Role of cMET in the development and progression of colorectal cancer
@en
prefLabel
Role of cMET in the development and progression of colorectal cancer
@en
P2093
P2860
P50
P356
P1476
Role of cMET in the development and progression of colorectal cancer
@en
P2093
Alessandra Castano
Ilaria Bossi
Pamela Biondani
P2860
P304
18056-18077
P356
10.3390/IJMS140918056
P407
P50
P5008
P577
2013-09-03T00:00:00Z